OVERVIEW
A live, virtual symposium in which 4 experts discuss evidence based recommendations and guidelines for the management of patients with hypertrophic cardiomyopathy (HCM). Using case examples, they will explore how physicians can best implement these guidelines in clinical practice. The faculty will also discuss novel and emerging therapies and techniques for diagnosing HCM. The session will conclude with a Q&A with the faculty.
Enhance Your Virtual Experience With Backstage Pass!
Join our 30-minute post-symposium breakout session connecting the program speakers and audience in the virtual environment. Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.
*Video Encouraged*
GOAL STATEMENT
The goal of this activity is that learners will be more familiar with novel therapeutics, including myostatin inhibitors, in the area of hypertrophic cardiomyopathy (HCM).
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the [LIST] [ITEM]Clinical data on emerging therapies for obstructive HCM [ITEM]Clinical data on emerging cardiac imaging techniques used in the diagnosis of HCM [/LIST] Have greater competence related to [LIST] [ITEM] Implementing current guideline recommendations for the management of HCM [/LIST] Demonstrate greater confidence in their ability to [LIST] [ITEM]Use evidence-based recommendations for the management of HCM [/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.0 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.